Zobrazeno 1 - 10
of 177
pro vyhledávání: '"Leeman JR"'
Autor:
Yamauchi H; Lamont-Doherty Earth Observatory, Columbia University, Palisades, New York 10964, USA., McCarthy C; Lamont-Doherty Earth Observatory, Columbia University, Palisades, New York 10964, USA., Leeman JR; Leeman Geophysical LLC, Gentry, Arkansas 72734, USA., Holtzman BK; Lamont-Doherty Earth Observatory, Columbia University, Palisades, New York 10964, USA.
Publikováno v:
The Review of scientific instruments [Rev Sci Instrum] 2024 Jul 01; Vol. 95 (7).
Autor:
Leeman Jr., George B.
Publikováno v:
ACM Transactions on Programming Languages & Systems; Jan1986, Vol. 8 Issue 1, p50-87, 38p
Autor:
VIKBERG, Tommy1 tommy.vikberg@ri.se, HANSSON, Lars2,3 laha@ntnu.no
Publikováno v:
Pro Ligno. Mar2024, Vol. 20 Issue 1, p3-8. 6p.
Autor:
Farmer LJ; Vertex Pharmaceuticals Inc. , 50 Northern Avenue, Boston, Massachusetts 02210, United States., Clark MP; Vertex Pharmaceuticals Inc. , 50 Northern Avenue, Boston, Massachusetts 02210, United States., Boyd MJ; Vertex Pharmaceuticals Inc. , 50 Northern Avenue, Boston, Massachusetts 02210, United States., Perola E; Vertex Pharmaceuticals Inc. , 50 Northern Avenue, Boston, Massachusetts 02210, United States., Jones SM; Vertex Pharmaceuticals Inc. , 50 Northern Avenue, Boston, Massachusetts 02210, United States., Tsai A; Vertex Pharmaceuticals Inc. , 50 Northern Avenue, Boston, Massachusetts 02210, United States., Jacobs MD; Vertex Pharmaceuticals Inc. , 50 Northern Avenue, Boston, Massachusetts 02210, United States., Bandarage UK; Vertex Pharmaceuticals Inc. , 50 Northern Avenue, Boston, Massachusetts 02210, United States., Ledeboer MW; Vertex Pharmaceuticals Inc. , 50 Northern Avenue, Boston, Massachusetts 02210, United States., Wang T; Vertex Pharmaceuticals Inc. , 50 Northern Avenue, Boston, Massachusetts 02210, United States., Deng H; Vertex Pharmaceuticals Inc. , 50 Northern Avenue, Boston, Massachusetts 02210, United States., Ledford B; Vertex Pharmaceuticals Inc. , 50 Northern Avenue, Boston, Massachusetts 02210, United States., Gu W; Vertex Pharmaceuticals Inc. , 50 Northern Avenue, Boston, Massachusetts 02210, United States., Duffy JP; Vertex Pharmaceuticals Inc. , 50 Northern Avenue, Boston, Massachusetts 02210, United States., Bethiel RS; Vertex Pharmaceuticals Inc. , 50 Northern Avenue, Boston, Massachusetts 02210, United States., Shannon D; Vertex Pharmaceuticals Inc. , 50 Northern Avenue, Boston, Massachusetts 02210, United States., Byrn RA; Vertex Pharmaceuticals Inc. , 50 Northern Avenue, Boston, Massachusetts 02210, United States., Leeman JR; Vertex Pharmaceuticals Inc. , 50 Northern Avenue, Boston, Massachusetts 02210, United States., Rijnbrand R; Vertex Pharmaceuticals Inc. , 50 Northern Avenue, Boston, Massachusetts 02210, United States., Bennett HB; Vertex Pharmaceuticals Inc. , 50 Northern Avenue, Boston, Massachusetts 02210, United States., O'Brien C; Vertex Pharmaceuticals Inc. , 50 Northern Avenue, Boston, Massachusetts 02210, United States., Memmott C; Vertex Pharmaceuticals Inc. , 50 Northern Avenue, Boston, Massachusetts 02210, United States., Nti-Addae K; Vertex Pharmaceuticals Inc. , 50 Northern Avenue, Boston, Massachusetts 02210, United States., Bennani YL; Vertex Pharmaceuticals Inc. , 50 Northern Avenue, Boston, Massachusetts 02210, United States., Charifson PS; Vertex Pharmaceuticals Inc. , 50 Northern Avenue, Boston, Massachusetts 02210, United States.
Publikováno v:
ACS medicinal chemistry letters [ACS Med Chem Lett] 2017 Jan 20; Vol. 8 (2), pp. 256-260. Date of Electronic Publication: 2017 Jan 20 (Print Publication: 2017).
Autor:
Bandarage UK; Vertex Pharmaceuticals Incorporated , 50 Northern Avenue, Boston, Massachusetts 02210, United States., Clark MP; Vertex Pharmaceuticals Incorporated , 50 Northern Avenue, Boston, Massachusetts 02210, United States., Perola E; Vertex Pharmaceuticals Incorporated , 50 Northern Avenue, Boston, Massachusetts 02210, United States., Gao H; Vertex Pharmaceuticals Incorporated , 50 Northern Avenue, Boston, Massachusetts 02210, United States., Jacobs MD; Vertex Pharmaceuticals Incorporated , 50 Northern Avenue, Boston, Massachusetts 02210, United States., Tsai A; Vertex Pharmaceuticals Incorporated , 50 Northern Avenue, Boston, Massachusetts 02210, United States., Gillespie J; Vertex Pharmaceuticals Incorporated , 50 Northern Avenue, Boston, Massachusetts 02210, United States., Kennedy JM; Vertex Pharmaceuticals Incorporated , 50 Northern Avenue, Boston, Massachusetts 02210, United States., Maltais F; Vertex Pharmaceuticals Incorporated , 50 Northern Avenue, Boston, Massachusetts 02210, United States., Ledeboer MW; Vertex Pharmaceuticals Incorporated , 50 Northern Avenue, Boston, Massachusetts 02210, United States., Davies I; Vertex Pharmaceuticals Incorporated , 50 Northern Avenue, Boston, Massachusetts 02210, United States., Gu W; Vertex Pharmaceuticals Incorporated , 50 Northern Avenue, Boston, Massachusetts 02210, United States., Byrn RA; Vertex Pharmaceuticals Incorporated , 50 Northern Avenue, Boston, Massachusetts 02210, United States., Nti Addae K; Vertex Pharmaceuticals Incorporated , 50 Northern Avenue, Boston, Massachusetts 02210, United States., Bennett H; Vertex Pharmaceuticals Incorporated , 50 Northern Avenue, Boston, Massachusetts 02210, United States., Leeman JR; Vertex Pharmaceuticals Incorporated , 50 Northern Avenue, Boston, Massachusetts 02210, United States., Jones SM; Vertex Pharmaceuticals Incorporated , 50 Northern Avenue, Boston, Massachusetts 02210, United States., O'Brien C; Vertex Pharmaceuticals Incorporated , 50 Northern Avenue, Boston, Massachusetts 02210, United States., Memmott C; Vertex Pharmaceuticals Incorporated , 50 Northern Avenue, Boston, Massachusetts 02210, United States., Bennani Y; Vertex Pharmaceuticals Incorporated , 50 Northern Avenue, Boston, Massachusetts 02210, United States., Charifson PS; Vertex Pharmaceuticals Incorporated , 50 Northern Avenue, Boston, Massachusetts 02210, United States.
Publikováno v:
ACS medicinal chemistry letters [ACS Med Chem Lett] 2017 Jan 18; Vol. 8 (2), pp. 261-265. Date of Electronic Publication: 2017 Jan 18 (Print Publication: 2017).
Autor:
Leeman JR; Department of Geosciences, The Pennsylvania State University, 522 Deike Building, University Park, Pennsylvania 16802, USA., Saffer DM; Department of Geosciences, The Pennsylvania State University, 522 Deike Building, University Park, Pennsylvania 16802, USA., Scuderi MM; Department of Geosciences, The Pennsylvania State University, 522 Deike Building, University Park, Pennsylvania 16802, USA.; Dipartimento di Scienze della Terra, Sapienza Università di Roma, Piazzale Aldo Moro 5, 00185 Rome Italy., Marone C; Department of Geosciences, The Pennsylvania State University, 522 Deike Building, University Park, Pennsylvania 16802, USA.
Publikováno v:
Nature communications [Nat Commun] 2016 Mar 31; Vol. 7, pp. 11104. Date of Electronic Publication: 2016 Mar 31.
Autor:
Tsai AW; Department of Drug Metabolism and Pharmacokinetics, Vertex Pharmaceuticals Inc., Boston, Massachusetts, USA alice_tsai@vrtx.com., McNeil CF; Department of Infectious Diseases, Vertex Pharmaceuticals Inc., Boston, Massachusetts, USA., Leeman JR; Department of Infectious Diseases, Vertex Pharmaceuticals Inc., Boston, Massachusetts, USA., Bennett HB; Department of Infectious Diseases, Vertex Pharmaceuticals Inc., Boston, Massachusetts, USA., Nti-Addae K; Department of Materials Discovery and Characterization, Vertex Pharmaceuticals Inc., Boston, Massachusetts, USA., Huang C; Department of Drug Metabolism and Pharmacokinetics, Vertex Pharmaceuticals Inc., Boston, Massachusetts, USA., Germann UA; OnKognos Scientific Consulting and Services, Newton, Massachusetts, USA., Byrn RA; Department of Infectious Diseases, Vertex Pharmaceuticals Inc., Boston, Massachusetts, USA., Berlioz-Seux F; Department of Drug Metabolism and Pharmacokinetics, Vertex Pharmaceuticals Inc., Boston, Massachusetts, USA., Rijnbrand R; Department of Infectious Diseases, Vertex Pharmaceuticals Inc., Boston, Massachusetts, USA., Clark MP; Department of Chemistry, Vertex Pharmaceuticals Inc., Boston, Massachusetts, USA., Charifson PS; Department of Chemistry, Vertex Pharmaceuticals Inc., Boston, Massachusetts, USA., Jones SM; Department of Infectious Diseases, Vertex Pharmaceuticals Inc., Boston, Massachusetts, USA.
Publikováno v:
Antimicrobial agents and chemotherapy [Antimicrob Agents Chemother] 2015 Oct; Vol. 59 (10), pp. 6007-16. Date of Electronic Publication: 2015 Jul 13.
Autor:
Boyd MJ; Vertex Pharmaceuticals Inc., 50 Northern Avenue, Boston, MA, USA. Electronic address: Michael_Boyd@vrtx.com., Bandarage UK; Vertex Pharmaceuticals Inc., 50 Northern Avenue, Boston, MA, USA., Bennett H; Vertex Pharmaceuticals Inc., 50 Northern Avenue, Boston, MA, USA., Byrn RR; Vertex Pharmaceuticals Inc., 50 Northern Avenue, Boston, MA, USA., Davies I; Vertex Pharmaceuticals Inc., 50 Northern Avenue, Boston, MA, USA., Gu W; Vertex Pharmaceuticals Inc., 50 Northern Avenue, Boston, MA, USA., Jacobs M; Vertex Pharmaceuticals Inc., 50 Northern Avenue, Boston, MA, USA., Ledeboer MW; Vertex Pharmaceuticals Inc., 50 Northern Avenue, Boston, MA, USA., Ledford B; Vertex Pharmaceuticals Inc., 50 Northern Avenue, Boston, MA, USA., Leeman JR; Vertex Pharmaceuticals Inc., 50 Northern Avenue, Boston, MA, USA., Perola E; Vertex Pharmaceuticals Inc., 50 Northern Avenue, Boston, MA, USA., Wang T; Vertex Pharmaceuticals Inc., 50 Northern Avenue, Boston, MA, USA., Bennani Y; Vertex Pharmaceuticals Inc., 50 Northern Avenue, Boston, MA, USA., Clark MP; Vertex Pharmaceuticals Inc., 50 Northern Avenue, Boston, MA, USA., Charifson PS; Vertex Pharmaceuticals Inc., 50 Northern Avenue, Boston, MA, USA.
Publikováno v:
Bioorganic & medicinal chemistry letters [Bioorg Med Chem Lett] 2015 May 01; Vol. 25 (9), pp. 1990-4. Date of Electronic Publication: 2015 Mar 14.
Autor:
Byrn RA; Department of Infectious Diseases, Vertex Pharmaceuticals Incorporated, Boston, Massachusetts, USA., Jones SM; Department of Infectious Diseases, Vertex Pharmaceuticals Incorporated, Boston, Massachusetts, USA., Bennett HB; Department of Infectious Diseases, Vertex Pharmaceuticals Incorporated, Boston, Massachusetts, USA., Bral C; Department of Drug Safety Evaluation, Vertex Pharmaceuticals Incorporated, Boston, Massachusetts, USA., Clark MP; Department of Chemistry, Vertex Pharmaceuticals Incorporated, Boston, Massachusetts, USA., Jacobs MD; Department of Protein Sciences, Vertex Pharmaceuticals Incorporated, Boston, Massachusetts, USA., Kwong AD; InnovaTID Pharmaceuticals, Cambridge, Massachusetts, USA., Ledeboer MW; Department of Chemistry, Vertex Pharmaceuticals Incorporated, Boston, Massachusetts, USA., Leeman JR; Department of Infectious Diseases, Vertex Pharmaceuticals Incorporated, Boston, Massachusetts, USA., McNeil CF; Department of Infectious Diseases, Vertex Pharmaceuticals Incorporated, Boston, Massachusetts, USA., Murcko MA; Disruptive Biomedical, LLC, Holliston, Massachusetts, USA., Nezami A; Department of Protein Sciences, Vertex Pharmaceuticals Incorporated, Boston, Massachusetts, USA., Perola E; Department of Computational Sciences, Vertex Pharmaceuticals Incorporated, Boston, Massachusetts, USA., Rijnbrand R; Department of Infectious Diseases, Vertex Pharmaceuticals Incorporated, Boston, Massachusetts, USA., Saxena K; Department of Protein Sciences, Vertex Pharmaceuticals Incorporated, Boston, Massachusetts, USA., Tsai AW; Department of Drug Metabolism and Pharmacokinetics, Vertex Pharmaceuticals Incorporated, Boston, Massachusetts, USA., Zhou Y; Department of Infectious Diseases, Vertex Pharmaceuticals Incorporated, Boston, Massachusetts, USA., Charifson PS; Department of Chemistry, Vertex Pharmaceuticals Incorporated, Boston, Massachusetts, USA paul_charifson@vrtx.com.
Publikováno v:
Antimicrobial agents and chemotherapy [Antimicrob Agents Chemother] 2015 Mar; Vol. 59 (3), pp. 1569-82. Date of Electronic Publication: 2014 Dec 29.
Autor:
Clark MP; Vertex Pharmaceuticals Inc. , 50 Northern Ave, Boston, Massachusetts 02210, United States., Ledeboer MW, Davies I, Byrn RA, Jones SM, Perola E, Tsai A, Jacobs M, Nti-Addae K, Bandarage UK, Boyd MJ, Bethiel RS, Court JJ, Deng H, Duffy JP, Dorsch WA, Farmer LJ, Gao H, Gu W, Jackson K, Jacobs DH, Kennedy JM, Ledford B, Liang J, Maltais F, Murcko M, Wang T, Wannamaker MW, Bennett HB, Leeman JR, McNeil C, Taylor WP, Memmott C, Jiang M, Rijnbrand R, Bral C, Germann U, Nezami A, Zhang Y, Salituro FG, Bennani YL, Charifson PS
Publikováno v:
Journal of medicinal chemistry [J Med Chem] 2014 Aug 14; Vol. 57 (15), pp. 6668-78. Date of Electronic Publication: 2014 Jul 24.